跳至主要内容
临床试验/JPRN-UMIN000042932
JPRN-UMIN000042932招募中未知

A phase I/II study of neoadjuvant chemoradiotherapy for pancreatic cancer. - J-PACS 05

The Jikei University school of medicine0 个研究点目标入组 58 人开始时间: 2021年1月31日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
58

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Exclude non-curative factors found during radical resection 2) Have overt pulmonary fibrosis or interstitial pneumonia 3) Concomitant with active infectious diseases (HB, HCV, HIV infection, etc.) 4) Have uncontrollable diabetes, heart failure, angina, arrhythmia and myocardial infarction within 6 months of onset 5) Have watery diarrhea 6) Cases using flucytosine and phenytoin 7) Pregnant, lactating and likely or willing to become pregnant 8) Have a serious drug allergy 9) Have active double cancer (not applicable to cases 5 years after complete cure) 10) Have other serious complications 11) Have severe neuropsychiatric symptoms, renal impairment, hearing impairment 12) Chickenpox patients 13) Previous treatment history (surgical excision, chemotherapy, radiation, etc.) for this disease 14) In addition, the doctor in charge judged that it was inappropriate to carry out this study safely.

研究者

相似试验